All Type of News
Korea to promote biosimilar industry
The government recently unveiled its plan to nurture the biosimilar industry as one of its new growth engines, aiming to take a bigger share of the global market.
Biosimilars are officially approved subsequent vers...
Revised pharmacy dispensing fee takes effect from next January
The Ministry of Health and Welfare announced Wednesday that from next January, the revised pharmacy dispensing fee will be applicable and 72.2 billion won will be additionally saved by simplifying the pharmacy managem...
Pfizer’s Apixaban gets nod from KFDA
Pfizer Korea said that the Korea Food and Drug Administration have approved its Eliquis (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
...
Multinational firms eager to recruit young recruits
It has become more difficult for young people to get a job as local pharmaceutical companies do not offer as many new positions as they used to in the past, amid the uncertain outlooks due to the government’s plan to ...
Large law firms eye large-scale lawsuit in pharmaceutical sector
Major law firms are setting their sights on the pharmaceutical sector, encouraged by drug makers’ collective suit against the Ministry of Health and Welfare to slash drug prices starting next April.
The Korea Pharm...
Nucleoside to treat drug-resistant HBV presented at HEP-DART
Bukwang Pharmaceutical Co. announces that interim results of physician-sponsored studies of a novel antiviral compound ‘FMCA’ and its prodrugs for the treatment of chronic hepatitis B virus (HBV) was presented at the ...
Incentive to be offered for patients visiting neighborhood clinics
Starting next April, people suffering from chronic illnesses such as diabetes or hypertension will be able to get a discount on their medical bills if they register at a neighborhood clinic instead of visiting general...
Pharmacies alert over paparazzi
The government has provided financial incentives to people who uncover businesses violating the rules on correctly identifying the country of origin of meat. But it is feared the plan could have an unintended side eff...
Dong-A and Green Cross to see sustained growth next year
Despite the government’s pressure to cut drug prices and fierce competition, Dong-A Pharmaceutical and Green Cross Corp. will see their revenue and operating profit surge next year, according to a report released by I...
Local pharmaceutical industry in transition
The country’s pharmaceutical companies face tough times ahead of the government’s plan to slash drug prices. So far, the government’s tight control over drug pricing and reimbursement policies under the national healt...
